Nancy Cox, who for decades was a global leader in influenza research, has died. Cox headed the influenza team at the Centers ...

Torie Bosch: Whether it’s Ambien or Wegovy, ivermectin or fluoride, every drug in your medicine cabinet or advertised on TV ...

Trump's embrace of psychedelics and cannabis is shaking up the GOP’s relationship with mind-altering substances.

A Utah pilot to renew prescriptions using a bot faced backlash from the state's medical board, which called for an immediate ...

What did Eli Lilly see in a struggling biotech startup that made the pharma giant want to pay billions for it? Bryan Roberts ...

The problematic use of guest editors was spotlighted last week when a genetics journal retracted nearly an entire special ...

This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen ...

WASHINGTON — President Trump heralded a drug pricing agreement with Regeneron on Thursday, closing the last of 17 deals ...

State restrictions, Trump administration policies, and waning public support are further limiting adults' access to ...

BioAge is making its way into the race among drug companies to target inflammation as a way to treat chronic conditions.

The Trump administration, in a stark departure from the "Just Say No" era, is funding psychedelics research and rescheduling ...

Years later, I interned there as a health and science reporter and have since contributed as a freelancer. Reporting on ...